Evidence map›Paper›PMID 39883644›Full record

ArticlePloS one2025

Evaluation of the practical application of the category-imbalanced myeloid cell classification model.

Zhigang Hu, Aoru Ge, Xinzheng Wang, Cuisi Ou, Shen Wang, Junwen Wang

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zhigang HuSchool of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, China.
Aoru GeSchool of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, China.
Xinzheng WangSchool of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, China.ORCID 0000-0003-1624-8070
Cuisi OuSchool of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, China.
Shen WangSchool of Mechanical and Electrical Engineering, Henan University of Science and Technology, Luoyang, China.
Junwen WangSchool of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incidence of acute myeloid leukemia (AML) is increasing annually, and timely diagnostic and treatments can substantially improve patient survival rates. AML typing traditionally relies on manual microscopy for classifying and counting myeloid cells, which is time-consuming, laborious, and subjective. Therefore, developing a reliable automated model for myeloid cell classification is imperative. This study evaluated the performance of five widely-used classification models on the largest publicly available bone marrow cell dataset (BM). However, the accuracy of the classification model is significantly affected by the imbalance in the distribution of bone marrow cell types. To address this issue, this study analyzed five different Loss functions and seven different attention mechanisms. When the classification models is chosen, Swin Transformer V2 was found to perform the best. However, the lightweight model RegNetX-3.2gf had significantly fewer parameters and a significantly faster inference speed than Swin Transformer V2, and its F1 Score was only 0.032 lower than that of Swin Transformer V2. Accordingly, RegNetX-3.2gf is strongly recommended for practical applications. During the evaluation of Loss function and attention mechanism, the Cost-Sensitive Loss Function (CS) and the channel attention mechanism Squeeze-and-Excitation Networks (SE) demonstrated superior performance. The optimal model (RegNetX-3.2gf + CS + SE) achieved an average precision of 68.183%, an average recall of 63.722%, and an average F1 Score of 65.155%. This model exhibited significantly improved performance compared to the original dataset results, achieving an enhancement of 17.183% in precision and 10.655% in the F1 Score. Finally, the class activation maps demonstrate that our model focused on the cells themselves, especially on the nucleus when making classifications. It proved that our model was reliable. This study provided an important reference for the study of bone marrow cell classification and a practical application of the model, promoting the development of the intelligent classification of AML.

Indexed as

Leukemia, Myeloid, AcuteMyeloid CellsAlgorithmsBone Marrow CellsHumans

Identifiers

PMID39883644
PMCPMC11781689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.